SCHEMBL3156965

SCHEMBL3156965

CNCCC(=O)N(C)c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)OC)ccc32)c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP1 Q9P0U3 2/20 0.41
AAK1 Q2M2I8 1/20 0.40
CASP1 P29466 1/20 0.37
RXFP1 Q9HBX9 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
BACE1 P56817 2/20 0.35
POLB P06746 2/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
BLM P54132 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTPN1 P18031 1/20 0.34
HIF1A Q16665 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ABL1 P00519 1/20 0.34
NTRK1 P04629 1/20 0.34
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156977 1.00 SENP1 (0.41) SENP1AAK1CASP1RXFP1KMT2A
SCHEMBL3143050 0.94 SENP1 (0.44) SENP1RXFP1KMT2AMEN1TP53
SCHEMBL480448 0.94 SENP1 (0.44) SENP1RXFP1KMT2AMEN1TP53
SCHEMBL3158308 0.92 SENP1 (0.42) SENP1AAK1CASP1RXFP1KMT2A
SCHEMBL479538 0.92 SENP1 (0.42) SENP1AAK1CASP1RXFP1KMT2A
SCHEMBL3158303 0.92 SENP1 (0.42) SENP1AAK1CASP1RXFP1KMT2A
SCHEMBL479541 0.92 SENP1 (0.42) SENP1AAK1CASP1RXFP1KMT2A
SCHEMBL31093998 0.91 SENP1 (0.42) SENP1AAK1CASP1RXFP1KMT2A
SCHEMBL727111 0.91 SENP1 (0.42) SENP1AAK1CASP1RXFP1KMT2A
SCHEMBL2572795 0.91 SENP1 (0.42) SENP1AAK1CASP1RXFP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed